Hitachi Medical Systems
My language  EN FR DE IT ES 
Please download the Flash Player to view this content

Welcome to Hitachi Medical Systems Europe - former Aloka Holding Europe website

Aloka Holding Europe AG, Switzerland, a former subsidiary of Hitachi Aloka Medical Ltd., was legally integrated into Hitachi Medical Systems Europe Holding AG, Switzerland, on 1 December 2011. Hitachi Medical Systems Europe Holding AG is a subsidiary of Hitachi Medical Corporation and Hitachi Aloka Medical Ltd., both based in Tokyo, Japan. The two entities will combine their broad experience  and knowledge, synergizing the expertise and talents on both sides to  offer their customers an even more attractive range of medical  ultrasound solutions. Aloka has an exceptional history as an innovator  in ultrasound and is renowned for high-quality ultrasound systems and  support. Combining both product lines will allow them to broaden the  participation and penetration of this large and diverse market.

>> Press Release (PDF)

 


ProSound 
Ultrasound Systems

  • F37 F37
    Thoroughly simple and compact. As a user-friendly diagnostic ultrasound system full of functional and ergonomic features, F37 is ready to be your partner. The F37’s simple operational features provide an easy... [more]

ProSound 
Medical Applications

  • Cardiovascular Cardiovascular
    Hitachi Aloka is proud of the reputation we’ve built over the last 60 years as an industry leader in diagnostic ultrasound. Known for our unparalleled image quality, superior system reliability and intuitive use... [more]

ProSound 
Technologies

  • Broadband Harmonics Broadband Harmonics
    Broadband harmonics uses the broadband and large amplitude transmission typically represented by compound impulse waveform transmission. The technique of removing the fundamental wave components by phase modulation is... [more]

HI VISION Systems - Applications - Technologies

What our customers say

'Ultrasound guided liver surgery makes tumour removal safer'
Using ultrasound systems to treat previously unfeasible cases and to avoid major hepatectomies is an important life-saving development in the treatment of liver cancer.

Professor Torzilli, Associate Professor of Surgery, School of Medicine, University of Milan & Director of Liver Surgery at Instituto Clinico Humanitas, Milan.

© Hitachi Medical Systems Europe 1994, 2011. All rights reserved.